Atlas Trials

Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

Clinical trial NCT02842021 · TERMINATED

Trial details

NCT number
NCT02842021
Sponsor
Sol-Gel Technologies, Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Tinea Pedis
Start date
2016-09-01
Primary completion
2017-10-01
Enrollment
283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.